# Non-alcoholic Fatty Liver trials recruiting: 66 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 66 trials with no drug phase for Non-alcoholic Fatty Liver Disease that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Non-alcoholic Fatty Liver Disease trials with no drug phase: 66 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/non-alcoholic-fatty-liver-disease

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 66
- Recruiting or not yet: 66
- Read on: November 19, 2026

## Trials

The 25 newest of 66, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 6, 2026 | NCT07922720 | Efficacy of Carnitine Complex in Improving Hepatic Steatosis in Potential Liver Donors | Samsung Medical Center | Not applicable | Not yet recruiting | Hepatic Steatosis, Fatty Liver, Non-Alcoholic Fatty Liver Disease, Metabolic Dysfunction-Associated Steatotic Liver... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922720) |
| September 22, 2026 | NCT07832994 | Metaboic Syndrome and Fatty Liver in Celiac Disease Females: Reponse to Exercise in Adolescents | Cairo University | Not applicable | Recruiting | Celiac Disease, Metabolic Syndrome, Non Alcoholic Fatty Liver | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07832994) |
| September 15, 2026 | NCT07820800 | NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP) | University of Eastern Finland | Not applicable | Recruiting | Type 2 Diabetes, Coronary Heart Disease, Myocardial Infarction, Cerebrovascular Disease, Stroke, Chronic Kidney... | 1,400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07820800) |
| September 1, 2026 | NCT07797101 | Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis | The Second Affiliated Hospital of Chongqing Medical University | Not applicable | Not yet recruiting | Cirrhosis, Portal Hypertension, Fatty Liver Disease, GLP-1 | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07797101) |
| July 31, 2026 | NCT07740109 | The Effects of 5-methyltetrahydrofolate Supplementation in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease | Tabriz University of Medical Sciences | Not applicable | Not yet recruiting | Nonalcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease (NAFLD), MASLD - Metabolic Dysfunction-Associated... | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07740109) |
| July 20, 2026 | NCT07713992 | Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease... | Tianjin Medical University | Not applicable | Not yet recruiting | Type 2 Diabetes Mellitus (T2DM), Nonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes Melitus | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07713992) |
| July 13, 2026 | NCT07697313 | High-intensity Interval Training Versus Moderate Intensity Continuous Training on Gut Microbiota in Non-alcoholic Fatty Liver | Horus University | Not applicable | Not yet recruiting | Non-alcoholic Fatty Liver | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697313) |
| May 20, 2026 | NCT07599241 | Additive Efficacy of Physical Activity Program in Hypthyroidism Elder Females With Glaucoma and Fatty Liver Issues | Cairo University | Not applicable | Recruiting | Subclinical hypothyroïdism, Non-Alcoholic Fatty Liver Disease, Primary Open Angle Glaucoma | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07599241) |
| May 6, 2026 | NCT07570810 | Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM | Shanghai Jiao Tong University School of Medicine | Not applicable | Not yet recruiting | Type 2 Diabetes, Obesity, Non-alcoholic Fatty Liver Disease | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07570810) |
| March 27, 2026 | NCT07497750 | Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver Disease - A... | University Hospital, Toulouse | Not applicable | Not yet recruiting | Non Alcoholic Fatty Liver Disease | 216 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07497750) |
| January 29, 2026 | NCT07376486 | Duodenal pulsENDO as an Early Treatment for Type 2 DM | Chinese University of Hong Kong | Not applicable | Recruiting | Diabete Mellitus, T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07376486) |
| December 8, 2025 | NCT07270601 | Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis | ContextVision AB | Not applicable | Recruiting | MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, NAFLD - Non-Alcoholic Fatty Liver Disease | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07270601) |
| November 20, 2025 | NCT07237750 | iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) +Optimized Lifestyle Intervention (OLI) vs Sham + OLI for Weight Loss | Sponsor not shown (see the record) | Not applicable | Recruiting | Overweight and/or Obesity, Metabolic Syndrome, Nonalcoholic Fatty Liver Disease | 216 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07237750) |
| August 19, 2025 | NCT07130318 | Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise | Cairo University | Not applicable | Recruiting | Familial Mediterranean Fever, Non-Alcoholic Fatty Liver Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07130318) |
| July 30, 2025 | NCT07093346 | The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic... | University of Nottingham | Not applicable | Recruiting | Nonalcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease (NAFLD), MASLD - Metabolic Dysfunction-Associated... | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07093346) |
| July 16, 2025 | NCT07068191 | Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly | Phenomen Pharma | Not applicable | Recruiting | Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD), Hepatomegaly, Nonalcoholic Fatty Liver (NAFL)... | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07068191) |
| April 17, 2025 | NCT06932289 | Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions | VA Greater Los Angeles Healthcare System | Not applicable | Not yet recruiting | NAFLD (Nonalcoholic Fatty Liver Disease) | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06932289) |
| March 21, 2025 | NCT06890169 | OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities | Changi General Hospital | Not applicable | Recruiting | Obesity and Type 2 Diabetes, NAFLD - Non-Alcoholic Fatty Liver Disease, Hypertension, Dyslipidaemia, Telemedicine | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06890169) |
| March 4, 2025 | NCT06856252 | Human Liver ORganoids as a Model to Study the Development of Non-Alcoholic SteatOhepatitis (NASH) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Not applicable | Recruiting | NAFLD | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06856252) |
| January 31, 2025 | NCT06803108 | Pyramidal Versus Continuous Training Effects on Fatty Liver | Cairo University | Not applicable | Recruiting | Non-Alcoholic Fatty Liver Disease | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06803108) |
| December 30, 2024 | NCT06751862 | The Role of Sugars in Fat Accumulation in the Liver | Institute for Clinical and Experimental Medicine | Not applicable | Recruiting | Fatty Liver Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06751862) |
| December 16, 2024 | NCT06735118 | Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver | Yunnan Cancer Hospital | Not applicable | Recruiting | Non-Alcoholic Fatty Liver Disease | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06735118) |
| December 10, 2024 | NCT06727279 | Assessment of Tolerability of Specialized Food Products Made Out of Vegetable Protein and Their Influence on Lipid Profile in Patients With... | Federal State Budgetary Scientific Institution | Not applicable | Not yet recruiting | Non-alcoholic Fatty Liver Disease NAFLD | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06727279) |
| December 5, 2024 | NCT06718842 | Walking Program in Fatty Liver Children With Phenylketonuria | Cairo University | Not applicable | Recruiting | Phenylketonurias, Non Alcoholic Fatty Liver | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06718842) |
| December 5, 2024 | NCT06717828 | The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults | Fujian Provincial Hospital | Not applicable | Recruiting | Non-Alcoholic Fatty Liver Disease | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06717828) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Cairo University | 5 |
| University Hospital, Angers | 3 |
| Chinese University of Hong Kong | 2 |
| Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | 2 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2 |
| Federal State Budgetary Scientific Institution | 1 |
| University of Nottingham | 1 |
| Medical University of Vienna | 1 |
| The University of Hong Kong | 1 |
| VA Greater Los Angeles Healthcare System | 1 |
| University of Lisbon | 1 |
| Yale University | 1 |
| Ziekenhuis Oost-Limburg | 1 |
| Steno Diabetes Center Copenhagen | 1 |
| University Hospital, Lille | 1 |
| Fujian Provincial Hospital | 1 |
| Hospices Civils de Lyon | 1 |
| [Perspectum](https://specstream.ai/data/clinical-trials/company/perspectum) | 1 |
| Mayo Clinic | 1 |
| Changi General Hospital | 1 |
| Stanford University | 1 |
| University Hospital, Basel, Switzerland | 1 |
| Uppsala University | 1 |
| Yunnan Cancer Hospital | 1 |
| Universitas Diponegoro | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 12 |
| France | 7 |
| Egypt | 6 |
| Italy | 5 |
| Hong Kong | 3 |
| Denmark | 3 |
| China | 3 |
| Canada | 2 |
| Czechia | 2 |
| United Kingdom | 1 |
| Austria | 1 |
| Belgium | 1 |
| Singapore | 1 |
| Switzerland | 1 |
| Sweden | 1 |
| Indonesia | 1 |
| Chile | 1 |
| Netherlands | 1 |
| Cyprus | 1 |
| Taiwan | 1 |
| Finland | 1 |
| Iran | 1 |
| Russia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [DUI law firms in the United States](https://specstream.ai/data/businesses/dui-law-firms/united-states)
- [Paper mills in the United States](https://specstream.ai/data/businesses/paper-mills/united-states)
- [Auto insurance agencies in the United States](https://specstream.ai/data/businesses/auto-insurance-agencies/united-states)
- [Graphic design firms in the United States](https://specstream.ai/data/businesses/graphic-design-firms/united-states)
- [Sawmills in the United States](https://specstream.ai/data/businesses/sawmills/united-states)
- [Carpet cleaning companies in the United States](https://specstream.ai/data/businesses/carpet-cleaning-companies/united-states)
